The Undercovered Dozen series spotlights 12 lesser-known stocks highlighted in recent Seeking Alpha articles. This week's edition covers articles published between Oct. 31 and Nov. 7, offering fresh investment ideas. The series aims to inspire discussion and help investors discover overlooked opportunities in the market.
Merck said on Tuesday that it has entered into an agreement to receive funds managed by Blackstone Life Sciences for $700 million to develop an experimental cancer therapy.
NEW YORK--(BUSINESS WIRE)--Blackstone (NYSE: BX) announced the completion of the previously announced offering of $600 million of 4.300% senior notes due 2030 and $600 million of 4.950% senior notes due 2036 of Blackstone Reg Finance Co. L.L.C., its indirect subsidiary. The notes are fully and unconditionally guaranteed by Blackstone Inc. and its indirect subsidiaries, Blackstone Holdings I L.P...
These two high-yield powerhouses offer retirees dependable income backed by investment-grade balance sheets. They offer current yields between 7-11.7%. We detail why they are attractive buys right now.
Blackstone (BX) shares are now at the seventh day of an ongoing losing streak, accumulating total losses of -9.3% during this timeframe. The recent sell off follows the company's mixed Q3 2025 earnings.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.